AGILE THERAPEUTICS INC Annual Net Income (Loss) Attributable to Parent in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Agile Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
  • Agile Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$11.9M, a 212% decline year-over-year.
  • Agile Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$15.9M, a 16.8% increase year-over-year.
  • Agile Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$14.5M, a 43.1% increase from 2022.
  • Agile Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$25.4M, a 64.2% increase from 2021.
  • Agile Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$71.1M, a 37.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$14.5M +$10.9M +43.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$25.4M +$45.7M +64.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$71.1M -$19.2M -37.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 -$51.9M -$33.2M -179% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 -$18.6M +$1.17M +5.93% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
2018 -$19.8M +$8.53M +30.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$28.3M +$437K +1.52% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-20
2016 -$28.7M +$1.59M +5.26% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 -$30.3M -$14.3M -88.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$16.1M -$1.76M -12.3% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-26
2013 -$14.3M +$8.94M +38.4% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-26
2012 -$23.3M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.